Efficacy of Dupilumab for Atopic Dermatitis According to Clinical Course and Clinical Findings: A Multicentre Retrospective Study

Efficacy of Dupilumab for Atopic Dermatitis According to Clinical Course and Clinical Findings: A Multicentre Retrospective Study

Abstract is missing (Short communication)

Bibliographic Details
Main Authors:	Takeshi Nakahara, Makiko Kido-Nakahara, Daisuke Onozuka, Sawako Sakai, Tomoko Hirose, Nobutoshi Take, Akiko Sugiyama, Kayo Harada, Gaku Tsuji, Satoko Kikuchi, Futoshi Kohda
Format:	Article
Language:	English
Published:	Medical Journals Sweden 2021-11-01
Series:	Acta Dermato-Venereologica
Subjects:	atopic dermatitis dupilumab eczema area and severity index itch numerical rating scale patient-oriented eczema measure
Online Access:	https://medicaljournalssweden.se/actadv/article/view/369

Similar Items

Quick Treatment of Very Severe Refractory Hand and Foot Eczema with Dupilumab: A Case Report and Literature Review
by: Li Y, et al.
Published: (2023-01-01)

Efficacy and Safety of Dupilumab in the Treatment of Hand Eczema: A Retrospective Study
by: Claudia Paganini, et al.
Published: (2024-03-01)

Occupational Chronic Hand Dermatitis in Hospital Environment Successfully Treated with Dupilumab: A Case Report
by: Hui Gan, et al.
Published: (2022-08-01)

Conjunctivitis in patients with atopic dermatitis treated with dupilumab
by: Sandra Ferreira, et al.
Published: (2020-05-01)

Dupilumab Versus Cyclosporine for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity Index
by: Lieneke F.M. Ariëns, et al.
Published: (2019-06-01)

Effectiveness and safety of dupilumab in adults with moderate and severe atopic dermatitis in Colombia: Real-life experience
by: Julián Londoño, MD, et al.
Published: (2023-04-01)

Current Clinical Options for the Management of Itch in Atopic Dermatitis
by: Lipman ZM, et al.
Published: (2021-08-01)

Disidrose: aspectos clínicos, etiopatogênicos e terapêuticos Dyshidrotic eczema: clinical, etiopathogenic and therapeutic aspects
by: Lorivaldo Minelli, et al.
Published: (2008-04-01)

The application of the biological treatment in atopic dermatitis: focus on dupilumab
by: Yu. S. Smolkin, et al.
Published: (2023-03-01)

Efficacy of Dupilumab on Different Phenotypes of Adult with Moderate-to-Severe Atopic Dermatitis in Taiwan: A Real-World Study
by: Chin-Yi Yang, et al.
Published: (2022-10-01)

Identification of clinical predictors for dupilumab dose spacing in adults with atopic dermatitis: a real-world study
by: Andrea Chiricozzi, et al.
Published: (2023-12-01)

A case report of uveitis secondary to dupilumab treatment for atopic dermatitis
by: Marissa Ayasse, BS, et al.
Published: (2021-01-01)

Dupilumab for occupational irritant hand dermatitis in a nonatopic individual: A case report
by: Gefei Alex Zhu, MD, et al.
Published: (2020-04-01)

Dupilumab Treatment Leads to Rapid and Consistent Improvement of Atopic Dermatitis in All Anatomical Regions in Patients Aged 6 Months to 5 Years
by: Elaine C. Siegfried, et al.
Published: (2023-07-01)

Spotlight on dupilumab in the treatment of atopic dermatitis: design, development, and potential place in therapy
by: D’Erme AM, et al.
Published: (2017-05-01)

Did dupilumab unmask smoldering mycosis fungoides?
by: Michelle Toker, BS, et al.
Published: (2023-08-01)

Current Perspectives on the Systemic Management of Atopic Dermatitis
by: Davari DR, et al.
Published: (2021-06-01)

Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6–11 Years of Age with Severe Atopic Dermatitis
by: Michael J. Cork, et al.
Published: (2023-09-01)

Clinically Meaningful Responses to Dupilumab Among Children Aged 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis who did Not Achieve Clear or Almost Clear Skin According to the Investigator’s Global Assessment: A Post Hoc Analysis of a Phase 3 Trial
by: Michael J. Cork, et al.
Published: (2024-02-01)

[Artículo traducido]Eficacia y seguridad de dupilumab para el tratamiento de la dermatitis atópica grave en la práctica clínica: experiencia en un centro terciario
by: A. Martínez-Doménech, et al.
Published: (2024-02-01)

Eczema control and treatment satisfaction in atopic dermatitis patients treated with dupilumab – a cross-sectional study from the BioDay registry
by: Jart A. F. Oosterhaven, et al.
Published: (2022-05-01)

Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Dermatitis
by: Kim Rand, et al.
Published: (2023-10-01)

Dupilumab as promising treatment for prurigo nodularis: current evidences
by: Ludovica Toffoli, et al.
Published: (2022-04-01)

Letter to the Editor Regarding ‘Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab Versus Dupilumab in Moderate-to-Severe Atopic Dermatitis’
by: Mike Bastian, et al.
Published: (2024-02-01)

Novel topical and systemic therapies in atopic dermatitis
by: Hiraku Suga, et al.
Published: (2019-04-01)

A review of dupilumab in the treatment of atopic diseases
by: Quinn Thibodeaux, et al.
Published: (2019-09-01)

Management of Atopic Dermatitis: Clinical Utility of Ruxolitinib
by: Owji S, et al.
Published: (2022-10-01)

Hand Eczema in High School Students in Poland: A Cross-sectional Study
by: Marta Szepietowska, et al.
Published: (2024-01-01)

Pathomechanism of Pruritus in Psoriasis and Atopic Dermatitis: Novel Approaches, Similarities and Differences
by: Agnieszka Kaczmarska, et al.
Published: (2023-09-01)

Emerging Methods to Objectively Assess Pruritus in Atopic Dermatitis
by: Mary Patricia Smith, et al.
Published: (2019-06-01)

Dupilumab use in dermatologic conditions beyond atopic dermatitis – a systematic review
by: Aleksi J. Hendricks, et al.
Published: (2021-01-01)

Case Report: Dupilumab Successfully Controls Severe Eczema in a Child With Elevated IgE Levels and Recurrent Skin Infections
by: Tejas P. Joshi, et al.
Published: (2021-09-01)

An Open Trial on the Feasibility and Efficacy of a Mindfulness-Based Intervention with Psychoeducational Elements on Atopic Eczema and Chronic Itch
by: Julia Harfensteller
Published: (2022-03-01)

Retrospective Study of Dupilumab Treatment for Moderate to Severe Atopic Dermatitis in Korea: Efficacy and Safety of Dupilumab in Real-World Practice
by: Dong Hyek Jang, et al.
Published: (2020-06-01)

Insect Bite Hypersensitivity in Horses: Causes, Diagnosis, Scoring and New Therapies
by: Abbey Cox, et al.
Published: (2023-08-01)

Dupilumab for the treatment of prurigo nodularis: A systematic review
by: Peng Cao, et al.
Published: (2023-01-01)

Dupilumab as a combination therapy to oral systemic immunomodulators for moderate-to-severe atopic dermatitis for skin of color children in resource-limited setting: A case series
by: Siti Nuraihan, et al.
Published: (2023-01-01)

The Psychology of Atopic Dermatitis
by: Ashling Courtney, et al.
Published: (2024-03-01)

Burden of Disease and Unmet Needs in the Diagnosis and Management of Atopic Dermatitis in the Arabic Population of the Middle East
by: Omar Mahmoud, et al.
Published: (2023-07-01)

Overview of Atopic Dermatitis in Different Ethnic Groups
by: Andrea Chiricozzi, et al.
Published: (2023-04-01)